|
"Chronic myeloid leukemia-- starting and stopping TKI therapy." |
03/06/2017 - 12:00pm to 1:00pm |
|
Annual Compliance Review |
10/10/2016 - 12:00pm to 1:00pm |
|
Annual fellow QI/Safety Project Presentations |
06/12/2017 - 12:00pm to 1:00pm |
|
Assessing inter-professional teamwork amongst health care workers involved in cancer care in SouthWestern Nigeria |
10/24/2016 - 12:00pm to 1:00pm |
|
BAP1 and Hereditary Mesothelioma & The Role of Adjuvant Systemic Therapy in Resected Non-Small Cell Lung Cancer |
10/31/2016 - 12:00pm to 1:00pm |
|
Breast and Ovarian Cancer Program |
07/18/2016 - 12:00pm to 1:00pm |
|
Cancer Treatment-Induced Bone Loss |
08/15/2016 - 12:00pm to 1:00pm |
|
Clinical and molecular characteristics of acquired resistance to anti-PD-1 therapy in NSCLC |
02/20/2017 - 12:00pm to 1:00pm |
|
Clinical Informatics Update – post RCTP and Future Vision |
11/21/2016 - 12:00pm to 1:00pm |
|
Defining leukemogenic mechanisms in hereditary hematologic malignancies |
11/14/2016 - 12:00pm to 1:00pm |
Facebook
Twitter
LinkedIn
Forward